A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
2020 · Nature · 4,813 citations
https://doi.org/10.1038/s41586-020-2286-9
O
Olivier Schwartz
Institut Pasteur(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
492
Papers
46.6K
Citations
100
h-index
289
i10-index
Olivier Schwartz is an academic researcher from Institut Pasteur. The author has contributed to research in topics: HIV Research and Treatment & SARS-CoV-2 and COVID-19 Research & Immune Cell Function and Interaction. The author has an h-index of 100, co-authored 419 publications.
ORCID: 0000-0002-0729-1475Papers by this author
worksAutoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
2021 · Nature · 2,151 citations
https://doi.org/10.1038/s41586-021-03777-9
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
2021 · Nature · 1,586 citations
https://doi.org/10.1038/s41586-021-04389-z
IgA dominates the early neutralizing antibody response to SARS-CoV-2
2020 · Science Translational Medicine · 1,115 citations
https://doi.org/10.1126/scitranslmed.abd2223
Syncytia formation by SARS‐CoV‐2‐infected cells
2020 · The EMBO Journal · 494 citations
https://doi.org/10.15252/embj.2020106267
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat